Table 1. Numbers of tumour specimens negative and positive for CC3 expression.
| Marker | Level of expression | Number of specimens (%) |
|---|---|---|
|
CC3 | ||
|
Tumour | ||
| |
Low (0–60 cells mm−2) |
43 (13) |
| |
High (61–max cells mm−2) |
314 (87) |
| |
Total |
334 (100) |
| |
Tumour-associated stroma |
|
| |
Low (0–104 cells mm−2) |
178 (56) |
| |
High (105–max cells mm−2) |
142 (44) |
| |
Total |
320 (100) |
|
MHC-II | ||
|
Tumour | ||
| |
Negative |
386 (94) |
| |
Positive |
27 (6) |
| |
Total |
413 (100) |
| |
Tumour-associated stroma |
|
| |
Negative |
213 (51) |
| |
Positive |
202 (49) |
| |
Total |
415 (100) |
|
Cleaved PARP | ||
|
Tumour | ||
| |
Low |
183 (90) |
| |
High |
23 (10) |
| |
Total |
206 |
| |
Tumour-associated stroma |
|
| |
Low |
189 (92) |
| |
High |
16 (8) |
| Total | 205 | |
Abbreviations: CC3=cleaved caspase-3; MHC-II=major histocompatibility class II; PARP=poly (ADP-ribose) polymerase.